Patent ID: 9724262
Date: 2017-08-08
CPC Classifications: A61D,A61H,A61K,G01N

Claim:
1. A method of reducing, ameliorating, mitigating and/or reversing a syndrome of reversion to fetal consciousness in a neonate mammal in need thereof, comprising: a) identifying a neonate mammal manifesting one or more clinical symptoms consistent with brain hypoxia selected from the group consisting of: mild obtundation, a stuperous state of consciousness, a comatose state of consciousness, lack of affinity for the mother, failure to nurse, blindness, vocalization, wandering, paroxysmal paddling and seizures; and b) administering to the neonate an effective amount of a 5α reductase inhibitor and/or subjecting the neonate to squeezing along the mid-thorax, wherein the squeezing applies substantially uniform pressure along the mid-thorax of the neonate and/or wherein the applied pressure of the squeezing is maintained for at least 10 minutes.